United Therapeutics | UTHR - Stock



United Therapeutics reported $169.2M in Stock for its fiscal quarter ending in June of 2025.


Stock Change Date
Amarin USD 224M 15.41M Sep/2024
Ardelyx USD 22.28M 1.11M Jun/2025
Baxter International USD 2.17B 124M Mar/2025
Bayer EUR 12.11B 576M Jun/2025
Biogen USD 2.27B 400K Jun/2025
BioMarin Pharmaceutical USD 1.34B 65.32M Jun/2025
Gilead Sciences USD 1.83B 66M Jun/2025
GlaxoSmithKline GBP 6.07B 72M Jun/2025
Halozyme Therapeutics USD 181.5M 16.64M Jun/2025
Insmed USD 107.6M 6.89M Jun/2025
Ionis Pharmaceuticals USD 8.48M 3.02M Jun/2025
J&J USD 12.66B 215M Mar/2025
Moderna USD 240M 112M Jun/2025
Pfizer USD 11.67B 817M Jun/2025
PTC Therapeutics USD 34.06M 12.39M Jun/2025
Regeneron Pharmaceuticals USD 3.21B 760.7M Jun/2025
Sarepta Therapeutics USD 994.04M 52.6M Jun/2025
Teva Pharmaceutical Industries USD 3.5B 250M Jun/2025
United Therapeutics USD 169.2M 3.8M Jun/2025
Vertex Pharmaceuticals USD 1.5B 139.6M Jun/2025